Currencies, stocks fall on vaccine efficacy worries



* Moderna CEO warns COVID-19 jabs less effective against Omicron

* MSCI EM stocks index set for monthly decline of 4%

* Turkey's lira falls for third straight session

By Shreyashi Sanyal

Nov 30 (Reuters) - Most emerging market currencies dipped on Tuesday on doubts over how effective COVID-19 vaccines are against the Omicron variant, while a gauge for stocks in the developing world was set for its biggest monthly decline in two months.

U.S. drugmaker Moderna's MRNA.O chief, Stéphane Bancel, warned that COVID-19 vaccines were unlikely to be as effective against the Omicron variant of the coronavirus as they have been against the Delta version.

The MSCI's index for emerging market stocks .MSCIEF fell 0.4%, set for monthly declines of 4%.

"This is not really new news relative to the last 3-4 days given what we know about the new mutation but the market is picking up on the explicit comments," said Deutsche Bank strategist Jim Reid.

"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that."

The warning comes a day after global financial markets started the week on firm footing, with analysts pointing to the new variant as a cause for central banks to rein in recent tightening of monetary policy.

Currencies in Asia gave back early gains, while units in Europe, Middle East and Africa were trading flat to lower by 0919 GMT. The drop in developing world currencies was also contained by a weaker U.S. dollar =USD .

South Africa's rand ZAR= dipped 0.1%, while stocks in the region logged the smallest declines among peers on higher gold prices.

Russia's rouble RUB= fell 0.4%, with sliding oil prices to blame. The Russian central bank said it will pursue monetary policy that will bring inflation back to its 4% target by the end of 2022.

LIRA TROUBLES LINGER

Turkey's lira TRY= fell in volatile trading for the third day in a row, amid a very low interest rate environment. Turkish President Tayyip Erdogan pledged on Monday to never defend interest rate hikes nor compromise on the issue.

Erdogan's tough stance on keeping interest rates low and influence over the country's central bank has pushed the lira to all-time lows, with the currency losing over 42% this year.

"What has been more interesting over the past couple of days is that the central bank and regulators have begun to intervene in various ways, targeting market participants with short lira positions," said Tatha Ghose, FX and EM analyst at Commerzbank.

"This shows that the authorities are not really comfortable with lira depreciation no matter how much they say that they want a weak lira."

Data showed Turkey's economy grew 7.4% year-on-year in the third quarter, meeting expectations failing to ease concerns about monetary policy.

For GRAPHIC on emerging market FX performance in 2021, see Link For GRAPHIC on MSCI emerging index performance in 2021, see Link

For TOP NEWS across emerging markets

For CENTRAL EUROPE market report, see

For TURKISH market report, see

For RUSSIAN market report, see
Reporting by Shreyashi Sanyal in Bengaluru, editing by Ed Osmond

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示: 您的資金存在風險。杠杆商品可能不適合所有客戶。 請詳細閱讀我們的風險聲明